8月21日 - ** 莫德纳（Moderna） MRNA.O 股价上涨14.5%，至152.60美元，收复了周四部分跌幅
** 周五的反弹标志着受莫德纳和默克 MRK.N 周三公布的晚期癌症疫苗临床试验数据 (link) 影响，股价已连续第三个交易日出现剧烈波动
** 周三，Moderna股价暴涨近177% (link)，周四则暴跌23.6% (link)，由于周五未发布新的临床信息，mRNA概念股行情持续剧烈震荡
** MRNA股票成交量超过4530万股，约为该股30日平均成交量的3倍
** 默克公司股价上涨近3%，而纳斯达克生物技术指数 .NBI 上涨1.9%
** 受试验结果影响，本周至少有七家券商上调了对莫德纳的目标价
** 截至上一交易日收盘，MRNA今年以来涨幅已超过五倍
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.